Brief: Core Laboratories Provides Q1 Outlook

Core Laboratories

01/02/2023 23:30

Feb 1 (Reuters) - Core Laboratories NV  CLB.N :
    * FOURTH QUARTER REVENUE OF $128 MILLION
    * FOURTH QUARTER GAAP EPS OF $0.14; EX-ITEMS, $0.20
    * LOOKING FORWARD INTO 2023, SEES CRUDE-OIL MACRO
FUNDAMENTALS
CONTINUING TO SUPPORT MULTI-YEAR RECOVERY CYCLE FOR OIL,GAS
INDUSTRY
    * PROJECTS FIRST QUARTER 2023 REVENUE TO RANGE FROM $125
MILLION
TO $129 MILLION
    * EPS FOR THE FIRST QUARTER OF 2023 IS EXPECTED TO BE $0.14
TO
$0.19
    * Q4 EARNINGS PER SHARE VIEW $0.20, REVENUE VIEW $130.3
MILLION --
REFINITIV IBES DATA
    * Q1 EARNINGS PER SHARE VIEW $0.17, REVENUE VIEW $126.9
MILLION --
REFINITIV IBES DATA

Further company coverage:  CLB.N 
 ((Reuters.Briefs@thomsonreuters.com))